Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,246,061
+$308,371 QoQ
Shares Held
117,111
+17.1% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $496,284,956 across 119 Biotechnology names. DSGN ranks #79 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
483,971 | $24,585,726 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,760 | $20,434,531 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
277,114 | $17,375,047 | |
| 4 | EXEL |
Exelixis, Inc.
|
390,818 | $16,762,184 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
594,850 | $16,661,748 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
213,645 | $16,042,603 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
390,951 | $15,528,573 | |
| 8 | ASND |
Ascendis Pharma A/S
|
65,517 | $14,985,703 |
All Filings in DSGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,246,061 | 117,111 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $937,690 | 99,967 | Shares | Sole | 2026-02-17 | |
| 2023-06-30 | $293,101 | 46,524 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $293,341 | 50,839 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $188,869 | 11,296 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||